Filing Details
- Accession Number:
- 0000899243-23-019611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-28 17:30:09
- Reporting Period:
- 2023-09-26
- Accepted Time:
- 2023-09-28 17:30:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001233 | Sangamo Therapeutics Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
875045 | Biogen Inc. | 225 Binney St. Cambridge MA 02142 | No | No | Yes | No | |
1810387 | Biogen Ma Inc. | 225 Binney St. Cambridge MA 02142 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-09-26 | 6,000,000 | $0.50 | 17,652,466 | No | 4 | S | Indirect | By Biogen MA Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Biogen MA Inc. |
Footnotes
- Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc.